Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

HighWire full text link HighWire Free PMC article
Full text links

Actions

doi: 10.1136/gutjnl-2017-314205. Epub 2017 Nov 4.

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota

Affiliations

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota

Rui M Ferreira et al. Gut.2018 Feb.

Abstract

Objective: Gastric carcinoma development is triggered byHelicobacter pylori. ChronicH. pylori infection leads to reduced acid secretion, which may allow the growth of a different gastric bacterial community. This change in the microbiome may increase aggression to the gastric mucosa and contribute to malignancy. Our aim was to evaluate the composition of the gastric microbiota in chronic gastritis and in gastric carcinoma.

Design: The gastric microbiota was retrospectively investigated in 54 patients with gastric carcinoma and 81 patients with chronic gastritis by 16S rRNA gene profiling, using next-generation sequencing. Differences in microbial composition of the two patient groups were assessed using linear discriminant analysis effect size. Associations between the most relevant taxa and clinical diagnosis were validated by real-time quantitative PCR. Predictive functional profiling of microbial communities was obtained with PICRUSt.

Results: The gastric carcinoma microbiota was characterised by reduced microbial diversity, by decreased abundance ofHelicobacter and by the enrichment of other bacterial genera, mostly represented by intestinal commensals. The combination of these taxa into a microbial dysbiosis index revealed that dysbiosis has excellent capacity to discriminate between gastritis and gastric carcinoma. Analysis of the functional features of the microbiota was compatible with the presence of a nitrosating microbial community in carcinoma. The major observations were confirmed in validation cohorts from different geographic origins.

Conclusions: Detailed analysis of the gastric microbiota revealed for the first time that patients with gastric carcinoma exhibit a dysbiotic microbial community with genotoxic potential, which is distinct from that of patients with chronic gastritis.

Keywords: Helicobacter pylori; bacterial infection; gastric carcinoma; gastritis.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The gastric microbiota profile differs in chronic gastritis and gastric carcinoma. (A) Shannon index of diversity in patients with chronic gastritis and gastric carcinoma. (B) Good’s estimator of coverage, measuring the proportion of total bacterial species represented in samples of each group of patients. Principal coordinate analysis (PCoA) plots of (C) unweighted and (D) weighted UniFrac distances in which samples were coloured by clinical outcome. The percentage of diversity captured by each coordinate is shown. ANOSIM, analysis of similarity.
Figure 2
Figure 2
The influence ofHelicobacter pylori in the microbiota composition of chronic gastritis and gastric carcinoma. (A) Relative abundance of phyla in all subjects and in each group of patients. (B) Spearman’s rank correlation between relative abundance ofHelicobacter spp. and non-Helicobacter Proteobacteria in all patients. Principal coordinate analysis (PCoA) plots of the weighted UniFrac distance matrix coloured by (C) increasing relative abundance ofHelicobacter and of (D) non-Helicobacter Proteobacteria.
Figure 3
Figure 3
Microbial taxa associated with gastric carcinoma. (A) Cladogram representation of the gastric microbiota taxa associated with chronic gastritis and gastric carcinoma. (B) Association of specific microbiota taxa with the group of chronic gastritis and gastric carcinoma by linear discriminant analysis (LDA) effect size (LEfSe). Green indicates taxa enriched in chronic gastritis group and red indicates taxa enriched in gastric carcinoma group. (C) Relative abundance of the 10 genera differentially enriched in the two clinical settings across Portuguese discovery and Chinese validation cohorts. *Significance obtained by LEfSe analysis atP<0.05. (D,E) Validation of LEfSe results by quantitative PCR (qPCR) of the 10 genera differentially enriched in the discovery cohort (D) and in the Portuguese validation cohort (E). Significance was obtained by Student’s t-test.
Figure 4
Figure 4
Microbial dysbiosis is associated with gastric carcinoma. (A) Box plot showing the MDI in the discovery cohort and in the Chinese and Mexican validation cohorts. Significance was obtained by one-way analysis of variance (ANOVA) corrected with Holm-Sidak test for multiple comparisons. (B) Box plot showing the MDI of the Portuguese validation cohort. Significance was obtained by Student’s t-test. (C) Negative Pearson’s correlation between MDI and Shannon index. (D) Principal coordinate analysis (PCoA) plot of the weighted UniFrac distance coloured by increasing MDI. The percentage of diversity captured by each coordinate is shown. Mantel correlations controlled with 104 permutations were used to compare distances. (E,F) ROC curves analysis to evaluate the discriminatory potential of MDI in gastric carcinoma detection in the discovery cohort (E) and in the Portuguese validation cohort (F). AUC, area under the curve; MDI, microbial dysbiosis index; ROC, receiver operating characteristic.
Figure 5
Figure 5
The gastric carcinoma microbiota is characterised by nitrosating bacteria. Functional classification of the predicted metagenome content of the microbiota of chronic gastritis and gastric carcinoma using (A) COG and (B) KO. The normalised relative frequency of nitrate reductase and nitrite reductase in patients with chronic gastritis and gastric carcinoma is shown. Significance was considered for adjustedP<0.05. COG, Clusters of Orthologous Groups; KO, Kyoto Encyclopedia of Genes and Genome (KEGG) orthology; NADH, nicotinamide adenine dinucleotide; NO, nitric oxide; TMAO, trimethylamine N-oxide.
See this image and copyright information in PMC

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–6. 10.1002/ijc.29210 - DOI - PubMed
    1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735–40. - PubMed
    1. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe 2011;10:324–35. 10.1016/j.chom.2011.10.003 - DOI - PMC - PubMed
    1. El-Omar EM, Oien K, El-Nujumi A, et al. . Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15–24. 10.1016/S0016-5085(97)70075-1 - DOI - PubMed
    1. Fukase K, Kato M, Kikuchi S, et al. . Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392–7. 10.1016/S0140-6736(08)61159-9 - DOI - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
HighWire full text link HighWire Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp